These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 18650570)
21. [Tuberculosis and immigration: criticality and possible remedial actions]. D'Auria A; Renzi S; Napoli PA; Franco E Ig Sanita Pubbl; 2011; 67(6):793-804. PubMed ID: 22508649 [TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered. Laniado-Laborín R Expert Rev Respir Med; 2010 Apr; 4(2):143-6. PubMed ID: 20406077 [No Abstract] [Full Text] [Related]
23. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat]. Tärnvik A Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373 [No Abstract] [Full Text] [Related]
24. Managing drug resistant tuberculosis. Grant A; Gothard P; Thwaites G BMJ; 2008 Aug; 337():a1110. PubMed ID: 18755763 [No Abstract] [Full Text] [Related]
26. [Tuberculosis--still increasing threat. Time for mobilization over the national borders]. Larsson LO Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1882-3. PubMed ID: 19739439 [No Abstract] [Full Text] [Related]
27. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Traore H; Fissette K; Bastian I; Devleeschouwer M; Portaels F Int J Tuberc Lung Dis; 2000 May; 4(5):481-4. PubMed ID: 10815743 [TBL] [Abstract][Full Text] [Related]
28. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720 [TBL] [Abstract][Full Text] [Related]
30. Multidrug-resistant tuberculosis and the need for biosocial perspectives. Farmer P; Bayona J; Becerra M Int J Tuberc Lung Dis; 2001 Oct; 5(10):885-6. PubMed ID: 11605879 [No Abstract] [Full Text] [Related]
31. Multidrug-resistant and extensively drug-resistant tuberculosis. Chiang CY; Yew WW Int J Tuberc Lung Dis; 2009 Mar; 13(3):304-11. PubMed ID: 19275788 [No Abstract] [Full Text] [Related]
32. [Latin American guidelines for the diagnosis and management of drug-resistant tuberculosis]. Palmero DJ; Laniado Laborín R; Caminero Luna JA Arch Bronconeumol; 2008 Oct; 44(10):578. PubMed ID: 19006641 [No Abstract] [Full Text] [Related]
33. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997. Frieden TR; Munsiff SS; Ahuja SD Int J Tuberc Lung Dis; 2007 Jan; 11(1):116. PubMed ID: 17217141 [No Abstract] [Full Text] [Related]
34. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants. Atre SR; Mistry NF J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879 [TBL] [Abstract][Full Text] [Related]
35. 2010: the year in review, part I. Lalloo UG; Nyamande K; Dheda K Int J Tuberc Lung Dis; 2011 Sep; 15(9):1149-53. PubMed ID: 21943838 [No Abstract] [Full Text] [Related]